Cite
The development and SAR of pyrrolidine carboxamide 11β-HSD1 inhibitors
MLA
Cheng, Hengmiao, et al. “The Development and SAR of Pyrrolidine Carboxamide 11β-HSD1 Inhibitors.” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 9, May 2010, pp. 2897–902. EBSCOhost, https://doi.org/10.1016/j.bmcl.2010.03.032.
APA
Cheng, H., Hoffman, J., Le, P., Nair, S. K., Cripps, S., Matthews, J., Smith, C., Yang, M., Kupchinsky, S., Dress, K., Edwards, M., Cole, B., Walters, E., Loh, C., Ermolieff, J., Fanjul, A., Bhat, G. B., Herrera, J., Pauly, T., & Hosea, N. (2010). The development and SAR of pyrrolidine carboxamide 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters, 20(9), 2897–2902. https://doi.org/10.1016/j.bmcl.2010.03.032
Chicago
Cheng, Hengmiao, Jacqui Hoffman, Phuong Le, Sajiv K. Nair, Stephan Cripps, Jean Matthews, Christopher Smith, et al. 2010. “The Development and SAR of Pyrrolidine Carboxamide 11β-HSD1 Inhibitors.” Bioorganic & Medicinal Chemistry Letters 20 (9): 2897–2902. doi:10.1016/j.bmcl.2010.03.032.